Arena Pharmaceuticals, Inc.

NASDAQ: ARNA
$65.39
+$0.71 (+1.1%)
Closing price November 24, 2020
The Cowen biotechnology team has a list of top 10 surprises that are specific to the very hot biotechnology sector.
Source: Jon OggWith the government shut down and with the debt ceiling debate breathing down everyone’s neck, investors have to be wondering what they should buy, sell and hold (or even avoid)....
Source: ThinkstockIt is not unusual to see most research on Wall Street pretty much line up either for or against a company. Analysts typically look at the same metrics in the balance sheet and the...
U.S. equity markets opened higher this morning following upward revisions from the Bureau of Labor Statistics on non-farm payrolls in February and March and a larger-than-expected rise in payrolls in...
Source: ThinkstockDrug maker Arena Pharmaceuticals Inc. (NASDAQ: ARNA) has withdrawn its application for European regulatory approval of its weight-loss drug Belviq. The drug was approved for use in...
U.S. equity markets opened lower this morning following news out of China that government is about to tighten restrictions on real estate transactions. The news pushed the Shanghai exchange down...
U.S. equity markets opened lower this morning following a number of disappointing data releases in Europe and Asia. Eurozone PMI remains on the pessimistic side, with a reading of 47.9, and the...
Source: ThinkstockVIVUS Inc. (NASDAQ: VVUS) reported a quarterly loss of $0.56 per share on Monday, but this was not an earnings story. VIVUS remains a developing story about its obesity drug Qsymia....
Source: ThinkstockIf you are obese in Europe, you are not about to get a little pill to take to help you change. You will just have to lose that weight the old-fashioned way through diet, exercise,...
Source: Jon OggThese are some of this Wednesday’s top analyst upgrades, downgrades and initiations seen from Wall S. research calls. We have calls in banks, solar, tech, biotech and more.Arch Coal...
Source: ThinkstockAccording to the Centers for Disease Control (CDC), more than one-third (35.7%) of all adults in the United States are obese or very overweight. Obesity-related medical conditions...
U.S. equity markets opened about flat this morning following the holiday weekend in the U.S. Foreign markets were also more or less mixed. In Europe, the German and eurozone economic indexes came in...
Source: ThinkstockArena Pharmaceuticals Inc. (NASDAQ: ARNA) is posing yet one more threat to ambitious biotechs and drug-makers who are targeting the obesity market. Its stock is getting slapped by...
Source: ThinkstockBack in December, we took an in-depth look at what has become a crowded race in the obesity drug market. As we pointed out then, the race has become a battle of not only who has the...
Source: ThinkstockSome of the biggest business stories of the past year drew the most Internet search traffic to the newsmakers, which is really no big surprise. Whether just for curiosity or for...